Skip to content

Effectiveness of Homoeopathic medicine Gaultheria procumbence in the treatment of Rheumatoid arthritis

A Prospective Clinical case series study on Rheumatoid arthritis patients treated with Gaultheria procumbence 3CH by assessing C-reactive protein,Erythrocyte sedimentation rate & Rheumatoid factor.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/03/050189
Enrollment
38
Registered
2023-03-01
Start date
Unknown
Completion date
Unknown
Last updated
2024-10-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M057- Rheumatoid arthritis with rheumatoid factor without organ or systems involvement Health Condition 2: M059- Rheumatoid arthritis with rheumatoid factor, unspecified

Interventions

Intervention1: GAULTHERIA PROCUMBENCE 3CH: 5 MEDICATED GLOBULES OF 30 SIZE PILLS WILL BE PRESCRIBED ORALLY IN MORNING AND NIGHT EVERY DAY BEFORE FOOD TO EACH PATIENT FOR 9 MONTHS Control Intervention1

Sponsors

VINAYAKA MISSION HOMOEOPATHIC MEDICAL COLLEGE AND HOSPITAL
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: RHEUMATOID ARTHRITIS DIAGNOSED PATIENTS - SCORE 6 OR ABOVE IN ACR/EULAR (AMERICAN COLLEGE OF RHEUMATOLOGY - EUROPEAN LEAGUE AGAINST RHEUMATISM) CRITERIA

Exclusion criteria

Exclusion criteria: PATIENTS WITH MUSCULOSKELATAL STRUCTURAL DEFORMITIES PATIENTS UNDERGOING LONG TERM AND CONTINUING TRAETMENT FOR RHEUMATOID ARTHRITIS PREGNANT AND LACTATING FEMALES

Design outcomes

Primary

MeasureTime frame
reduction in serum levels of Rheumatoid factor, ESR, and C reactive proteinTimepoint: 9 months

Secondary

MeasureTime frame
Reduction in DAS 28 scoreTimepoint: 9 months;Reduction in score of Rheumatoid arthritis impact of disease (RAID) scaleTimepoint: 9 months

Countries

India

Contacts

Public ContactKAVYA M

Vinayaka Missions Homoeopathic Medical College and Hospital

venkathompath@gmail.com9865134561

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026